Elevance Health (WBO:ELV) Market Cap: €79,365 Mil (As of Jul. 02, 2026)


WBO:ELV Elevance Health Inc WBO:ELV
83 GF Score
Price €348.50
GF Value €425.57
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Elevance Health Market Cap?

Elevance Health WBO:ELV +2.74% 83 Market Cap is €79,365 Mil as of Jul. 02, 2026. GuruFocus rates WBO:ELV with a GF Score™ of 83/100 and a GF Value™ of €425.57 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 18 Healthcare Plans companies, Elevance Health ranks better than 83.33% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Elevance Health's share price for the quarter that ended in Mar. 2026 was €252.3. Elevance Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 217 Mil. Therefore, Elevance Health's market cap for the quarter that ended in Mar. 2026 was €54,842 Mil.

Elevance Health's quarterly market cap increased from Sep. 2025 (€60,660 Mil) to Dec. 2025 (€64,893 Mil) but then declined from Dec. 2025 (€64,893 Mil) to Mar. 2026 (€54,842 Mil).

Elevance Health's annual market cap declined from Dec. 2023 (€98,822 Mil) to Dec. 2024 (€80,710 Mil) and declined from Dec. 2024 (€80,710 Mil) to Dec. 2025 (€64,893 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Elevance Health's Enterprise Value for Today is €98,969 Mil.


Elevance Health  (WBO:ELV) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Elevance Health Market Cap Related Terms


Elevance Health Market Cap Historical Data

* Premium members only.

The historical data trend for Elevance Health's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Market Cap Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99,827.25 114,184.15 98,822.10 80,709.90 64,892.86

Elevance Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90,933.32 74,353.27 60,660.24 64,892.86 54,841.95

WBO:ELV vs CI, HUM, CVS: Market Cap Comparison

For the Healthcare Plans subindustry, Elevance Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health Market Cap vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's Market Cap distribution charts can be found below:

* The bar in red indicates where Elevance Health's Market Cap falls into.


WBO:ELV
83GF Score
Elevance Health Inc WBO:ELV
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Elevance Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€294*220.724
=€64,893

Elevance Health's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€252.3*217.368
=€54,842

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €79,365 Mil mean?
Elevance Health (WBO:ELV) has a Market Cap of €79,365 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Elevance Health and its competitors. According to the industry distribution chart, Elevance Health ranks #3 out of 18 companies in the Healthcare Plans industry, placing it in the top 16.7%.
Is Elevance Health's Market Cap too high?
Elevance Health's current Market Cap is €79,365 Mil. Based on the distribution chart, Elevance Health ranks #3 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Elevance Health has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Market Cap compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #3 out of 18 companies for Market Cap. This places Elevance Health in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 3,903.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Plans company?
The median Market Cap among Healthcare Plans companies is 3,903.89, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median Market Cap is 3,903.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current Market Cap is €79,365 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €425.57, compared to a current price of €348.50 — trading 18.1% below its estimated fair value. The current Market Cap is €79,365 Mil. Elevance Health's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current Market Cap is €79,365 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (WBO:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €348.50 is trading 18.1% below its estimated GF Value™ of €425.57. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for WBO:ELV:

  • Market Cap: €79,365 Mil
  • GF Value™: €425.57 vs. price of €348.50 (18.1% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
83GF Score

Get the complete analysis for WBO:ELV

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€348.50
Price
€425.57
GF Value